Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Intravenous Immunoglobulin Market, by Distribution Channel
1.4.2 LAMEA Intravenous Immunoglobulin Market, by Application
1.4.3 LAMEA Intravenous Immunoglobulin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Intravenous Immunoglobulin Market by Distribution Channel
3.1 LAMEA Hospital Pharmacy Market by Country
3.2 LAMEA Specialty Pharmacy Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Intravenous Immunoglobulin Market by Application
4.1 LAMEA Immunodeficiency Diseases Market by Country
4.2 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
4.3 LAMEA Hypogammaglobulinemia Market by Country
4.4 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
4.5 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country
4.6 LAMEA Kawasaki Disease Market by Country
4.7 LAMEA Guillain-Barre Syndrome Market by Country
4.8 LAMEA Immune thrombocytopenia (ITP) Market by Country
4.9 LAMEA Others Market by Country
Chapter 5. LAMEA Intravenous Immunoglobulin Market by Country
5.1 Brazil Intravenous Immunoglobulin Market
5.1.1 Brazil Intravenous Immunoglobulin Market by Distribution Channel
5.1.2 Brazil Intravenous Immunoglobulin Market by Application
5.2 Argentina Intravenous Immunoglobulin Market
5.2.1 Argentina Intravenous Immunoglobulin Market by Distribution Channel
5.2.2 Argentina Intravenous Immunoglobulin Market by Application
5.3 UAE Intravenous Immunoglobulin Market
5.3.1 UAE Intravenous Immunoglobulin Market by Distribution Channel
5.3.2 UAE Intravenous Immunoglobulin Market by Application
5.4 Saudi Arabia Intravenous Immunoglobulin Market
5.4.1 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel
5.4.2 Saudi Arabia Intravenous Immunoglobulin Market by Application
5.5 South Africa Intravenous Immunoglobulin Market
5.5.1 South Africa Intravenous Immunoglobulin Market by Distribution Channel
5.5.2 South Africa Intravenous Immunoglobulin Market by Application
5.6 Nigeria Intravenous Immunoglobulin Market
5.6.1 Nigeria Intravenous Immunoglobulin Market by Distribution Channel
5.6.2 Nigeria Intravenous Immunoglobulin Market by Application
5.7 Rest of LAMEA Intravenous Immunoglobulin Market
5.7.1 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel
5.7.2 Rest of LAMEA Intravenous Immunoglobulin Market by Application
Chapter 6. Company Profiles
6.1 Grifols, S.A
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.1.5.2 Acquisition and Mergers:
6.2 Takeda Pharmaceutical Company Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 Baxter International, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Biotest AG (Tiancheng International Investment Limited)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 LFB S.A.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 CSL Limited (CSL Behring)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Octapharma AG
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals and Trials:
6.8 Kedrion S.p.A
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 Bayer AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
Unique Offerings 